You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ICU-CARE: An interactive mobile app to enhance the efficiency of daily informal caregiving in the intensive care unit

    SBC: SILICON CURES LLC            Topic: NINR

    PROJECT SUMMARY Actively involving informal caregivers in direct patient care at the bedside in the intensive care unit (ICU) has the potential to improve patient, informal caregiver, and health care system outcomes. Practice guidelines call for the liberal inclusion of informal caregivers as active partners in ICU care, but there is a critical, unmet need to develop tools that effectively operati ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Precision MRI with a Novel Protein Contrast Agent for Early Detection and Staging of Lung Fibrosis

    SBC: INLIGHTA BIOSCIENCES L.L.C.            Topic: NHLBI

    Summary Lung diseases, such as interstitial lung diseases including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and acute viral infection are major leading causes of death worldwide. The recent increase due to air pollution, tobacco smoking is and use of E-cigarettes has grown rapidly in the US contributing to a sharp increase in chronic lung diseases. IPF is ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. F plus G RSV VLP Vaccine for Improved Safety and Efficacy

    SBC: RAZI PHARMA LLC            Topic: NIAID

    Project Summary Respiratory syncytial virus (RSV) is a leading cause of serious lower respiratory tract disease in infants and young children worldwide. Since infection induces only partial protection, it causes repeat infection and disease throughout life. Though a high priority for vaccine development no vaccine is yet available. The lack of success in developing a vaccine suggests novel strateg ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  4. Neural Stem Cell Extracellular Vesicle Treatment for Traumatic Brain Injury

    SBC: ARUNA BIO, INC.            Topic: NINDS

    Project Summary/AbstractTraumatic brain injury (TBI) is a universal health concern and is known as a “silent epidemic”. Each year in America, 2.53 million patients visit the emergency department after suffering a TBI of which 56,800 die and over 288,000 require hospitalization, rehabilitation programs, and long-term supportive care. Although the primary TBI event is typically acute, subsequent ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  5. Colon cancer prevention with non-systemic PDE5 inhibitors

    SBC: Targut Biotechnologies Inc.            Topic: 102

    Approximately 50,000 people will die from colorectal cancer (CRC) in the United States this year due to the late stage at diagnosis where treatments are largely ineffective. Primary prevention of CRC is therefore very important for high-risk patients. Chemoprevention agents are needed for CRC but nothing has been approved for this purpose. Extensive preclinical and epidemiological evidence show gr ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  6. A Precision Medicine Tool for Optimal Personalized Treatment in Patients with Acute Myeloid Leukemia

    SBC: SANICKA, INC            Topic: NCI

    Acute myeloid leukemia (AML) is an aggressive cancer of the bone marrow and peripheral blood with poor prognosis mostly due to relapse. Despite decades of improvements in chemo-immunotherapy (CIT) and, more recently, the use of hypomethylating agent (HMAs) and addition of novel small molecule inhibitors (SMIs) to back-bone chemotherapy, AML treatment selection and dosage remains mostly empiric, wi ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  7. Simulated Exposure Trainer (SET-VR): Implementing Targeted Experiential Training with a Virtual Patient

    SBC: VIRTUALLY BETTER INC            Topic: 104

    PROJECT SUMMARY/ABSTRACT Despite the existence of numerous, well-established evidence-based practices (EBPs) for mental disorders, it has been difficult to disseminate these practices in community settings. Exposure therapy for anxiety disorders represents one of the most glaring examples of this research-to-practice gap. Just as patients are anxious about approaching their fears, therapists are o ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  8. Feasibility study of novel hand hygiene formulations against bacterial spore infection

    SBC: CAMELLIX, LLC            Topic: NIAID

    Project Summary: Spore-forming bacterial species, such as various Bacilli and Clostridia, undergo a sporulation process under unfavorable conditions to form dormant spores. These bacterial spores have become a threat to the food industry as they can cause food spoilage and food poisoning. In addition, an opportunistic pathogen, Clostridium difficile (C. difficile), one of the five CDC- listed urge ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Nasal Formulations Containing EC16 for Minimizing COVID-19-Associated Anosmia

    SBC: CAMELLIX, LLC            Topic: NIDCD

    Project Summary/Abstract SARS-CoV-2 infection is associated with high mortality and morbidity worldwide. A common sequela is anosmia, the loss of the sense of smell, which can impact the quality of life severely. This is due to the robust replication of SARS-CoV-2 in the nasal neuroepithelial cells, leading to acute or chronic olfactory dysfunction (anosmia). A significant number of patients in th ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  10. Decentralized Data Fusion Algorithm for Multisensor Radiation Source Search

    SBC: GLOBAL TECHNOLOGY CONNECTION, INC.            Topic: DTRA21B003

    The Defense Threat Reduction Agency (DTRA) desires innovative technology solutions to link radiation detectors of various resolutions to accelerate and improve the efficacy of nuclear search operations. Global Technology Connection, Inc. (GTC), in collaboration with our Research Institute (RI) and industrial partners, proposes to develop a scalable, locally hosted data fusion algorithm to accurat ...

    STTR Phase I 2022 Department of DefenseDefense Threat Reduction Agency
US Flag An Official Website of the United States Government